University Hospital Erlangen, Department of Vascular Surgery
Erlangen, Bavaria, 91054, Germany
Location contact
Rabah F. Sankari
SUB_INVESTIGATOR
Ulrich Rother, PD Dr. med.
CONTACT
NCT Number: NCT06994260
This clinical study evaluates the efficacy and accuracy of Multispectral Optoacoustic Tomography (MSOT) and Ultrasound Localization Microscopy (ULM) for imaging and diagnosing vascular malformations (venous, arteriovenous, lymphatic). The study aims to enhance diagnostic precision and improve treatment planning through advanced non-invasive imaging techniques.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Erlangen, Bavaria, 91054, Germany
Rabah F. Sankari
SUB_INVESTIGATOR
Ulrich Rother, PD Dr. med.
CONTACT
This study aims to investigate whether Multispectral Optoacoustic Tomography (MSOT) and Ultrasound Localization Microscopy (ULM) can accurately differentiate between lymphatic, venous, and arteriovenous vascular malformations. MSOT can determine oxygen levels based on the expected low oxygen content in venous blood, high oxygen content in arterial blood, and the absence of oxygen in lymphatic fluid. Additionally, ULM, utilizing microbubbles, measures blood flow velocities, which may help identify and distinguish these malformations or their mixed forms.
To date, vascular malformations of blood and lymphatic vessels are commonly diagnosed using cross-sectional imaging techniques such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI). MSOT introduces a novel, non-invasive diagnostic approach that enables the assessment of oxygenated hemoglobin concentrations and oxygen levels in blood and tissue. Previous studies (e.g., MSOT_IC, MSOT_PI) demonstrated the capability of MSOT to visualize muscle perfusion in patients with peripheral arterial disease. Moreover, it has successfully identified muscle structures and the clinical severity of Duchenne muscular dystrophy by detecting endogenous biomarkers like collagen and lipids.
The objective of this study is to utilize MSOT and ULM as supplementary diagnostic tools to conventional imaging methods to accurately identify and distinguish between venous, arteriovenous, and lymphatic malformations in patients. This approach has the potential to reduce exposure to ionizing radiation from CT scans and minimize the need for resource-intensive MRI procedures in the future.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MSOT is an advanced imaging technology that combines laser-induced ultrasound and light absorption to visualize biological tissues. By detecting ultrasound waves generated from tissue absorption of multispectral light, MSOT provides high-resolution, real-time images with functional and molecular information. One of its use is in biomedical research and clinical applications to study blood oxygenation and tissue composition, making it valuable for areas such as vascular research.
In this study, we aim to utilize MSOT to differentiate between venous, arteriovenous and lymphatic malformations.
ULM is a cutting-edge imaging technique that significantly enhances the resolution of traditional ultrasound by tracking the movement of microbubble contrast agents within blood vessels. This approach enables the visualization of microvascular structures and blood flow dynamics at a super-resolution scale, beyond the diffraction limit of conventional ultrasound.
In this study, we aim to utilize ULM to differentiate between venous, arteriovenous and lymphatic malformations.
Time frame: through study completion, an average of 1 year
using MSOT
Time frame: through study completion, an average of 1 year
using ULM
Contact information is provided by the study sponsor or research team.
University Hospital Erlangen
Other
Multispectral Optoacoustic Tomography (MSOT) and Ultrasound Localization Microscopy (ULM) as Diagnostic Imaging for Lymphatic, Venous and Arteriovenous Malformations
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06259292
Arteriovenous Malformations, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06986954
Aneurysm, False, Bleed Intracranial
Darien, Connecticut, United States
View Trial DetailsNCT04189172
Arnold-Chiari Malformation, Brain Diseases
Brest, France
View Trial DetailsNCT00833599
Adiposis Dolorosa, Cardiovascular Abnormalities
Houston, Texas, United States
View Trial Details